4 Merger and Acquisitions Stock Stories For Monday Diligence

Sprint Nextel Corporation (NYSE:S): Current price $7.08

On Monday, Sprint confirmed it received an unsolicited proposal from DISH Network (NASDAQ:DISH) to purchase it. The firm said that its board will evaluate this proposal carefully and consistent with its fiduciary and legal duties, but that it does not plan to comment further until the appropriate time.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

s

Thermo Fisher Scientific (NYSE:TMO): Current price $78.68

Thermo Fisher and Life Technologies Corporation have reached an agreement through which Thermo Fisher will purchase the latter for $76 in cash per fully diluted common share, or roughly $13.6 billion, along with the assumption of net debt at the close ($2.2 billion as of year end 2012). The transaction should close early in 2014.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

tmo

National Financial Partners Corp. (NYSE:NFP): Current price $25

The corporation announced Monday that it will be acquired by a controlled affiliate of Madison Dearborn. Through the terms, NFP shareholders will receive $25.35 in cash for each share of NFP common stock they own, in a transaction with an equity value of around $1.3 billion, which includes the full value of the firm’s convertible debt. The purchase price represents a premium of roughly 26 percent over NFP’s close of $20.05 on March 12, the last day of trading before press reports that NFP was considering a possible sale. The transaction should close in the third quarter.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

nfp

CareFusion Corp. (NYSE:CFN): Current price $34.33

The firm’s medical pumps, ventilators and medicine dispensers have already enticed the attention of investors who drove shares to a record last week, and now, it could get noticed by private-equity firms. The stocks have soared by 23 percent in 2013, as a turnaround plan helped expand margins and health-care stocks led the Standard & Poor’s 500 Index. CareFusion could be bought by a private-equity firm and then broken into pieces to boost returns, said B. Riley & Co.

Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.

cfn

Investing Insights: Is Procter and Gamble Still Bulletproof?